Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics
Journal of Cellular Physiology · 2024-11 · 239 (11)
DOI: 10.1002/jcp.31370 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, online erschienen am 10.07.2024. Verfasst von Hui Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunotherapy Laboratory, College of Pharmacology, Southwest Minzu University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Mitochondrial Dynamics, Mitochondria, Lung Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 216 Literaturangaben. Gefördert von: Southwest Minzu University Research Startup Funds, Innovative research project for Southwest Minzu University graduate students, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Mitochondria are dynamic organelles that continuously undergo fusion/fission to maintain normal cell physiological activities and energy metabolism. When mitochondrial dynamics is unbalanced, mitochondrial homeostasis is broken, thus damaging mitochondrial function. Accumulating evidence demonstrates that impairment in mitochondrial dynamics leads to lung tissue injury and pulmonary disease progression in a variety of disease models, including inflammatory responses, apoptosis, and barrier breakdown, and that the role of mitochondrial dynamics varies among pulmonary diseases. These findings suggest that modulation of mitochondrial dynamics may be considered as a valid therapeutic strategy in pulmonary diseases. In this review, we discuss the current evidence on the role of mitochondrial dynamics in pulmonary diseases, with a particular focus on its underlying mechanisms in the development of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis (PF), pulmonary arterial hypertension (PAH), lung cancer and bronchopulmonary dysplasia (BPD), and outline effective drugs targeting mitochondrial dynamics‐related proteins, highlighting the great potential of targeting mitochondrial dynamics in the treatment of pulmonary disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunotherapy Laboratory, College of Pharmacology, Southwest Minzu University, Chengdu, Sichuan, China.
- Immunotherapy Laboratory, College of Grassland Resources, Southwest Minzu University, Chengdu, Sichuan, China.
ORCID-Profile: Huiling Jiang
Förderung
- Southwest Minzu University Research Startup Funds
- Innovative research project for Southwest Minzu University graduate students
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Li, H., Dai, X., Zhou, J., Wang, Y., Zhang, S., Guo, J., Shen, L., Yan, H., & Jiang, H. (2024). Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics. Journal of Cellular Physiology, 239(11). https://doi.org/10.1002/jcp.31370
Vancouver
Li H, Dai X, Zhou J, Wang Y, Zhang S, Guo J, et al. Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics. Journal of Cellular Physiology. 2024;239(11). doi:10.1002/jcp.31370
BibTeX
@article{Li2024,
author = {Li, Hui and Dai, Xinyan and Zhou, Junfu and Wang, Yujuan and Zhang, Shiying and Guo, Jiacheng and Shen, Lidu and Yan, Hengxiu and Jiang, Huiling},
title = {Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics},
journal = {Journal of Cellular Physiology},
year = {2024},
volume = {239},
number = {11},
doi = {10.1002/jcp.31370}
}
EUVIMED